Sector Chart Omeros Corporation

Stocks

OMER

US6821431029

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 00:00:00 25/07/2026 +04			5-day change	1st Jan Change
9.790 ^USD	-4.77%		+1.03%	-43.00%

06-26	Omeros Corporation Provides Update On European Marketing Authorization Application For Narsoplimab In TA-TMA	CI
06-26	Omeros to Seek EMA Review After Negative Opinion on Narsoplimab Marketing Application	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes